We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App




Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing

By LabMedica International staff writers
Posted on 14 Jan 2022

The latest technology and innovation in the global fight against COVID-19 and beyond will be on show at the next edition of Medlab Middle East organized by Informa Markets (London, UK), when it returns to the Dubai World Trade Centre from 24-27 January 2022 with mobile molecular testing and diagnosis stations, or ‘laboratories on wheels’, from companies such as Seegene, Inc. More...

(Seoul, Korea) taking centre stage.

Mobile laboratories offer testing and diagnosis on the go, with many having the capacity to conduct upwards of 7,500 tests per day and a turnaround time of just 3.5 hours. The tests cover a variety of pathogens and offer a streamlined, automated workflow, from pre-extraction to data analysis. Typically, a mobile lab features an equipment room and an extraction room and laboratory. Technology within the station allows for automated testing with little supervision while incorporating other equipment such as RT-PCR reagents, consumables, and technical support for diagnostic testing. The other benefit mobile laboratories offer is they can be transported via ship or lorry to almost any place in the world and are fully operational within days of arrival. They can then conduct mass testing in schools, airports, or communities impacted by the pandemic.

Seegene will be among the companies to showcase its latest innovative products concerning COVID-19 testing during the event. The company recently partnered with Abu Dhabi’s G42 Healthcare to offer mobile laboratory stations across the Middle East and North Africa (MENA) region. In addition to highlighting the latest technology in the fight against COVID-19, the event will also see the return of the Medlab Middle East Congress COVID-19 Updates track. A number of global experts from USA, Europe and GCC will highlight further developments on COVID-19 vaccines and updates on the management of COVID-19 variants. The event will take place under strict protocols and enhanced measures that include 35 guidelines covering all aspects of cleaning and hygiene, social distancing measures, and the use of PPE, screening, and a track and trace in conjunction with local authorities.

“Mobile labs offers the most innovative mobile molecule diagnostic, testing and laboratory services and have had a major impact on the support they have been able to provide the healthcare community in combating COVID-19 infections,” said Tom Coleman, Exhibition Director for Informa Markets who are organizing Medlab Middle East. “As a result of COVID-19, we have seen the laboratory industry fast track a range of new cutting-edge technologies that have had a remarkable impact in the fight against the pandemic. Seegene’s Mobile Station is a prime example of accelerating transformation within the laboratory market, something we will be showcasing during Medlab Middle East in January.”

Related Links:
Seegene, Inc. 
Informa Markets


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The new analysis of blood samples links specific protein patterns to five- and ten-year mortality risk (Photo courtesy of Adobe Stock)

Blood Protein Profiles Predict Mortality Risk for Earlier Medical Intervention

Elevated levels of specific proteins in the blood can signal increased risk of mortality, according to new evidence showing that five proteins involved in cancer, inflammation, and cell regulation strongly... Read more

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: The SMART-ID Assay delivers broad pathogen detection without the need for culture (Photo courtesy of Scanogen)

Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples

Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.